|
|
![]() |
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
|
1. Methyl tertiary butyl ether (MTBE) is used as an oxygenating agent in petrol as it increases the octane rating of the fuel and reduces production of some air pollutants. In the UK, petrol typically contains up to 5% MTBE, the EC regulatory limit being 15% (from January 1st 2000: EC Directive 98/70/EC). 2. We are aware that the use of MTBE in the United States has given rise to two groups of complaints:
3. We are aware of the considerable volume of toxicological research that has been done on the possible effects of MTBE in experimental animals. We comment first on the results of these studies and then turn back to consider the reports of effects in man. 4. In terms of both acute and chronic dosing in experimental animals MTBE is a compound of low toxicity. Whilst there is evidence that large doses can produce cancer in animals, there is no indication that this occurs by mechanisms relevant to humans; effects are unlikely to be mediated by a genotoxic process. This being so, there is no case for assuming that inhalation of low concentrations of MTBE would be associated with a risk of cancer. Studies designed to investigate the possibility of reproductive and developmental toxicology are also reassuring. 5. Attention has been focussed on animal studies that have revealed neurotoxic effects at very high dose levels. We note the points made by the HEI panel who concluded that motor activity in rats was affected on exposure to 800 ppm MTBE and that at higher levels of exposure sedation and ataxia occurred. These are very high concentrations: 800 ppm is 3142 mg/m3. Ambient concentrations are likely to be < 10 µg/m3. Levels at petrol stations are significantly higher than this, reaching a peak of about 30 µg/m3 during refuelling. Details are provided on pages 10 and 11 of the HEI report and in the table attached at Appendix IV. Given that concentrations lower than 800 ppm were not studied in animal models and that effects were found at this level, it is not possible to identify a No Observed Adverse Effect Level as far as neurotoxic effects are concerned. We also note that the HEI report records exposure of workers involved in handling levels of MTBE of > 1000 ppm. This as a cause for concern and we return to this point in our conclusions. 6. Evidence of effects in populations exposed to petrol treated with MTBE has been reviewed in detail by the Health Effects Institute in their report: The Potential Health Effects of Oxygenates added to Gasoline (published in 1996). The community studies are difficult to evaluate because of problems of design and statistical power and also because of confounding produced by awareness that MTBE had been added to gasoline. We also note that experimental studies involving volunteers have failed to produce effects similar to those described in some community-based studies. No evidence of effects on psychomotor or psychometric functioning was produced in the volunteer studies. This is reassuring in view of the findings of neurotoxic effects in rats exposed to very high concentrations of MTBE. 7. Our conclusions from this review of the evidence and more recent literature are similar to those of the Health Effects Institute report:
|
|||||||||||||